Cargando…
The Value of FENO Measurement for Predicting Treatment Response in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
BACKGROUND: Fractional exhaled nitric oxide (FENO) has been shown to be a marker of airway inflammation in various pulmonary diseases, including chronic obstructive pulmonary disease (COPD). In this study, we assessed the FENO level in patients with acute exacerbations of COPD (AECOPD) and analyzed...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522317/ https://www.ncbi.nlm.nih.gov/pubmed/33061343 http://dx.doi.org/10.2147/COPD.S263673 |
_version_ | 1783588153732366336 |
---|---|
author | Zhou, Aiyuan Zhou, Zijing Deng, Dingding Zhao, Yiyang Duan, Jiaxi Cheng, Wei Liu, Cong Chen, Ping |
author_facet | Zhou, Aiyuan Zhou, Zijing Deng, Dingding Zhao, Yiyang Duan, Jiaxi Cheng, Wei Liu, Cong Chen, Ping |
author_sort | Zhou, Aiyuan |
collection | PubMed |
description | BACKGROUND: Fractional exhaled nitric oxide (FENO) has been shown to be a marker of airway inflammation in various pulmonary diseases, including chronic obstructive pulmonary disease (COPD). In this study, we assessed the FENO level in patients with acute exacerbations of COPD (AECOPD) and analyzed the predictive value of the FENO level for treatment response. METHODS: Demographic data were collected at admission. FENO, lung function, blood gases, COPD Assessment Test (CAT), and modified Medical Research Council (mMRC) scores were measured at admission and on day 7. At the second visit, the patients were asked to report their health status; scores ranged from 1 to 5, representing “much better”, “slightly better”, “no change”, “slightly worse”, and “much worse”, respectively. The treatment response was evaluated based on the patient’s reported health status (responders were those who reported much better and slightly better) and lung function (responders were those who presented an increase in FEV(1) over 200 mL). RESULTS: A total of 182 patients were recruited into the analysis. The FENO level positively correlated with an increase in FEV(1) and FEV(1)% (r = 0.291, p < 0.001 and r = 0.205, p = 0.005, respectively), but negatively correlated with a decrease in the COPD Assessment Test (CAT) score (r = −0.197, p = 0.008) and patient-reported health status (rho = −0.408, p<0.001). An inverse correlation was observed between FENO concentrations at admission and the length of hospital stay. The cut-off point for differentiating responders, identified by health status, was 18 ppb, with the sensitivity being 89.7% and specificity 88.9%. CONCLUSION: FENO levels, determined at hospital admission, are potential to predict the overall treatment response in AECOPD patients, including remission in subjective patient-reported health statuses and, also, improvements in lung function. REGISTRY NUMBER: ChiCTR-ROC-16,009,087 (http://www.chictr.org.cn/). |
format | Online Article Text |
id | pubmed-7522317 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-75223172020-10-14 The Value of FENO Measurement for Predicting Treatment Response in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Zhou, Aiyuan Zhou, Zijing Deng, Dingding Zhao, Yiyang Duan, Jiaxi Cheng, Wei Liu, Cong Chen, Ping Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: Fractional exhaled nitric oxide (FENO) has been shown to be a marker of airway inflammation in various pulmonary diseases, including chronic obstructive pulmonary disease (COPD). In this study, we assessed the FENO level in patients with acute exacerbations of COPD (AECOPD) and analyzed the predictive value of the FENO level for treatment response. METHODS: Demographic data were collected at admission. FENO, lung function, blood gases, COPD Assessment Test (CAT), and modified Medical Research Council (mMRC) scores were measured at admission and on day 7. At the second visit, the patients were asked to report their health status; scores ranged from 1 to 5, representing “much better”, “slightly better”, “no change”, “slightly worse”, and “much worse”, respectively. The treatment response was evaluated based on the patient’s reported health status (responders were those who reported much better and slightly better) and lung function (responders were those who presented an increase in FEV(1) over 200 mL). RESULTS: A total of 182 patients were recruited into the analysis. The FENO level positively correlated with an increase in FEV(1) and FEV(1)% (r = 0.291, p < 0.001 and r = 0.205, p = 0.005, respectively), but negatively correlated with a decrease in the COPD Assessment Test (CAT) score (r = −0.197, p = 0.008) and patient-reported health status (rho = −0.408, p<0.001). An inverse correlation was observed between FENO concentrations at admission and the length of hospital stay. The cut-off point for differentiating responders, identified by health status, was 18 ppb, with the sensitivity being 89.7% and specificity 88.9%. CONCLUSION: FENO levels, determined at hospital admission, are potential to predict the overall treatment response in AECOPD patients, including remission in subjective patient-reported health statuses and, also, improvements in lung function. REGISTRY NUMBER: ChiCTR-ROC-16,009,087 (http://www.chictr.org.cn/). Dove 2020-09-24 /pmc/articles/PMC7522317/ /pubmed/33061343 http://dx.doi.org/10.2147/COPD.S263673 Text en © 2020 Zhou et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhou, Aiyuan Zhou, Zijing Deng, Dingding Zhao, Yiyang Duan, Jiaxi Cheng, Wei Liu, Cong Chen, Ping The Value of FENO Measurement for Predicting Treatment Response in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease |
title | The Value of FENO Measurement for Predicting Treatment Response in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease |
title_full | The Value of FENO Measurement for Predicting Treatment Response in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease |
title_fullStr | The Value of FENO Measurement for Predicting Treatment Response in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease |
title_full_unstemmed | The Value of FENO Measurement for Predicting Treatment Response in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease |
title_short | The Value of FENO Measurement for Predicting Treatment Response in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease |
title_sort | value of feno measurement for predicting treatment response in patients with acute exacerbation of chronic obstructive pulmonary disease |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522317/ https://www.ncbi.nlm.nih.gov/pubmed/33061343 http://dx.doi.org/10.2147/COPD.S263673 |
work_keys_str_mv | AT zhouaiyuan thevalueoffenomeasurementforpredictingtreatmentresponseinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease AT zhouzijing thevalueoffenomeasurementforpredictingtreatmentresponseinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease AT dengdingding thevalueoffenomeasurementforpredictingtreatmentresponseinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease AT zhaoyiyang thevalueoffenomeasurementforpredictingtreatmentresponseinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease AT duanjiaxi thevalueoffenomeasurementforpredictingtreatmentresponseinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease AT chengwei thevalueoffenomeasurementforpredictingtreatmentresponseinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease AT liucong thevalueoffenomeasurementforpredictingtreatmentresponseinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease AT chenping thevalueoffenomeasurementforpredictingtreatmentresponseinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease AT zhouaiyuan valueoffenomeasurementforpredictingtreatmentresponseinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease AT zhouzijing valueoffenomeasurementforpredictingtreatmentresponseinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease AT dengdingding valueoffenomeasurementforpredictingtreatmentresponseinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease AT zhaoyiyang valueoffenomeasurementforpredictingtreatmentresponseinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease AT duanjiaxi valueoffenomeasurementforpredictingtreatmentresponseinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease AT chengwei valueoffenomeasurementforpredictingtreatmentresponseinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease AT liucong valueoffenomeasurementforpredictingtreatmentresponseinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease AT chenping valueoffenomeasurementforpredictingtreatmentresponseinpatientswithacuteexacerbationofchronicobstructivepulmonarydisease |